文献速递病毒性肝炎

欧洲消除丙型肝炎:能否实现世界卫生组织目标?

Elimination of hepatitis C in Europe: can WHO targets be achieved?
PubMed 文献 · Clin Microbiol Infect · 2020-01-21

综述评估欧洲丙肝消除进展,指出宏观消除策略难以实施,微消除在关键人群中有效,欧洲各国进展不一,部分国家达标而部分缺乏经济与政治支持,无预防性疫苗阻碍进程。

要点

  • 微消除策略在注射吸毒者等关键人群中显示有效
  • 欧洲各国消除进展速度不同,部分国家已达标
  • 无预防性疫苗,普遍治疗可作治疗性预防减少传播

核心结论

  • 全球消除丙肝看似可行,但许多国家可能无法在世卫组织建议时限内完成
  • 无疫苗情况下,普遍可及的治疗可作为减少传播的治疗性选项,尤其在高危人群

研究设计与样本

  • 综述近期文献及领域专家意见,聚焦欧洲丙肝消除规划

主要发现

  • 直接抗病毒药物治愈率超过95%
  • 宏观消除策略基于大规模筛查难以实施
  • 微消除有效性证据来自注射吸毒者等关键人群
  • 欧洲消除进展速度不同,部分国家达标,部分缺乏经济支持、政治倡导和基础设施

关键数值与推荐

  • 世卫组织提出2030年丙肝消除目标
  • 直接抗病毒药物治愈率超过95%

临床怎么用

  • 将消除目标分解为微消除目标以提高成功机会
  • 在注射吸毒者等高危人群中推进微消除
  • 无疫苗时,确保丙肝治疗普遍可及以降低传播

局限性

  • 基于文献综述与专家意见,非系统评价

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hepatitis C virus (HCV) infection affects 71 million people worldwide. The availability of highly efficient direct-acting antivirals has revolutionized the treatment landscape with over 95% cure rates. The WHO has launched a global programme to achieve rather ambitious HCV elimination targets for 2030. OBJECTIVES: This article aims to provide a critical overview of the current HCV elimination programmes in Europe highlighting the elements that should be implemented to achieve elimination and those that are already in place to promote this process. SOURCES: Review of the recently published literature and opinion of experts in the field. CONTENT: Elimination of hepatitis C as a public health threat appears to be a difficult task, which should be subdivided into smaller targets, the so-called micro-elimination goals, to increase chances of success. Macro-elimination strategies based on mass-screening are difficult to implement. Evidence supporting the efficacy of micro-elimination comes from key populations, such as people who inject drugs. HCV elimination is proceeding at different speeds in Europe. Some countries are on target with the WHO's objectives whereas others lack economic support and political advocacy, and have insufficient infrastructures to achieve this. The absence of an effective prophylactic vaccine is hampering the process and should be overcome. IMPLICATIONS: Elimination of hepatitis C worldwide appears plausible, but in several countries probably not within the time frame suggested by the WHO. In the absence of vaccination, universal access to HCV treatment would act as a 'therapeutic' option to reduce transmission, especially in high-risk populations.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Matičič M, Lombardi A, Mondelli MU, et al. Elimination of hepatitis C in Europe: can WHO targets be achieved? Clin Microbiol Infect. 2020. PMID: 31978546. doi:10.1016/j.cmi.2020.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。